Adagio Medical Holdings, Inc. (ADGM) vs Moleculin Biotech, Inc. (MBRX)

A side-by-side comparison of Adagio Medical Holdings, Inc. and Moleculin Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Adagio Medical Holdings, Inc. logo
ADGM
Adagio Medical Holdings, Inc.
$3M
$0.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Moleculin Biotech, Inc. logo
MBRX
Moleculin Biotech, Inc.
$2M
$0.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ADGM vs MBRX

growth of $100 · dividends reinvested · last 2y
ADGM -98.4% (-87.5%/yr)MBRX -99.4% (-92.2%/yr)ADGM compounded faster over this window
020406080100Start $10020252026$2$1
ADGM MBRX

ADGM vs MBRX: by the numbers

  • •ADGM is the larger company ($3M vs $2M market cap).

Metrics side by side

Valuation

MetricADGMMBRX
P/B ratioN/A0.21

Profitability

MetricADGMMBRX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-261.73%
ROIC-75.31%-242.25%

Growth (annualized)

MetricADGMMBRX
Total return CAGR (5Y)N/A-78.48%

Go deeper

Full ADGM analysisFull MBRX analysisInteractive comparison tool

Dig into the metrics

Adagio Medical ROEMoleculin Biotech ROEAdagio Medical operating marginMoleculin Biotech operating marginAdagio Medical revenue growthMoleculin Biotech revenue growthAdagio Medical free cash flowMoleculin Biotech free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.